3470-54-0

Basic information

• Product Name: 5-Aminoindan-1-one
• Synonyms: IFLAB-BB F0400-0036;5-AMINOINDAN-1-ONE;5-AMINO-1-INDANONE;5-Aminoindan-1-one, 95+%;5-amino-2,3-dihydroinden-1-one;5-aminoindanone;5-AMino-1-oxoindane;5-Amino-2,3-dihydro-1H-inden-1-one, 5-Amino-2,3-dihydro-1-oxo-1H-indene
• CAS NO: 3470-54-0
• Molecular Formula: C₉H₉NO
• Molecular Weight: 147.17
• Product Categories: Amines;Fused Ring Systems
• Mol File: 3470-54-0.mol

Chemical Properties

• Melting Point: 184 °C
• Boiling Point: 344.5 °C at 760 mmHg
• Flash Point: 162.1 °C
• Appearance: /Solid
• Density: 1.254 g/cm³
• Vapor Pressure: 6.57E-05mmHg at 25°C
• Refractive Index: 1.65
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 2.12±0.20(Predicted)
• CAS DataBase Reference: 5-Aminoindan-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Aminoindan-1-one(3470-54-0)
• EPA Substance Registry System: 5-Aminoindan-1-one(3470-54-0)

Safety Data

• Hazard Codes: Xn,Xi,T
• Statements: 20/21/22-52/53-25-52
• Safety Statements: 36/37-45
• RIDADR: UN 2811 6.1 / PGIII
• WGK Germany: 3
• HazardClass: 6.1
• Hazardous Substances Data: 3470-54-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5-Aminoindan-1-one is used as a key intermediate for the synthesis of various drugs and pharmaceuticals due to its ability to be easily modified and incorporated into complex molecular structures. Its presence in the molecular framework allows for the development of new therapeutic agents with potential applications in treating a range of diseases and conditions.
Used in Academic Research:
5-Aminoindan-1-one is utilized as a research tool in academic settings to explore its chemical properties, reactivity, and potential applications in the synthesis of novel compounds. Researchers use 5-Aminoindan-1-one to investigate new synthetic pathways and develop innovative methods for the preparation of biologically active molecules.
Used in Chemical Synthesis:
5-Aminoindan-1-one is employed as a versatile building block in the synthesis of a wide range of organic compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals. Its unique structure and reactivity make it an attractive candidate for the development of new synthetic routes and the production of advanced materials.
It is important to handle 5-Aminoindan-1-one with care, as it can be hazardous if not properly managed and used in accordance with safety guidelines. Proper handling and storage are essential to ensure the safety of individuals working with 5-Aminoindan-1-one and to prevent any potential adverse effects on the environment.

InChI:InChI=1/C9H9NO/c10-7-2-3-8-6(5-7)1-4-9(8)11/h2-3,5H,1,4,10H2

Upstream product

• 34598-49-7 5-Bromo-1-indanone 
• 58161-34-5 3-Acetaminohydrozimtsaeuremethylester 
• 4080-83-5 3-acetylaminobenzene propanoic acid 
• 59856-06-3 5-acetamidoindane 
• 58161-35-6 5-acetamido-1-indanone 
• 1116358-96-3 2-methyl-2-propanyl (1-oxo-2,3-dihydro-1H-inden-5-yl)carbamate 

Downstream Products

• 22246-24-8 5-nitro-2,3-dihydroinden-1-one 
• 511533-38-3 5-iodoindan-1-one 
• 70538-57-7 6-nitroisoquinoline 
• 75476-84-5 6-Iodoisoquinoline 
• 879499-96-4 1,1-dimethylethyl ((1S)-3-(methylthio)-1-{[(1-oxo-2,3-dihydro-1H-inden-5-yl)amino]carbonyl}propy)carbamate 
• 632-22-4 tetramethylurea 
• 869725-57-5 5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-ol 
• 150969-56-5 5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-one 
• 1264927-06-1 C₂₇H₂₃N₃O₂ 

Relevant articles and documents

The role of internal twisting in the photophysics of stilbazolium dyes

The synthesis of selectively bridged stilbazolium dyes related to DASPMI is described. The comparison of steady-state and time-resolved fluorescence studies as a function of temperature allows one to develop a kinetic model on the basis of which the high photostability and absence of photoisomerization for these dyes can be understood. There are two possible photochemical deactivation channels: non-radiative decay through single-bond twisting which does not lead to a distinguishable photoisomer and through double bond twisting leading to trans-cis photoisomerization. The latter process is more than one order of magnitude slower than single-bond twisting for these compounds and is only observed in the compound where both single bonds are bridged. Lifetime maxima observed at low temperature indicate a further early structural relaxation not connected with bond twisting but with bond length changes.

Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist

Interleukin-17 (IL-17) is a proinflammatory cytokine that plays a dominant role in inflammation, autoimmunity, and host defense. RORγt is a key transcription factor mediating T helper 17 (Th17) cell differentiation and IL-17 production, which is able to activate CD8+ T cells and elicit antitumor efficacy. A series of sulfonamide derivatives as novel RORγt inverse agonists were designed and synthesized. Using GSK2981278 (phase II) as a starting point, we engineered structural modifications that significantly improved the activity and pharmacokinetic profile. In animal studies, oral administration of compound d3 showed a robust and dose-dependent inhibition of the IL-17A cytokine expression in a mouse imiquimod-induced skin inflammation model. Docking analysis of the binding mode revealed that the compound d3 occupied the active pocket suitably. Thus, compound d3 was selected as a clinical compound for the treatment of Th17-driven autoimmune diseases.

Conformationally constrained analogues of N′-(4-tert-butylbenzyl)-N-(4-methylsulfonylaminobenzyl)thiourea as TRPV1 antagonists

A series of bicyclic analogues having indan and tetrahydronaphthalene templates in the A-region were designed as conformationally constrained analogues of our previously reported potent TRPV1 antagonists (1, 3). The activities for rat TRPV1 of the conformationally restricted analogues were moderately or markedly diminished, particularly in the case of the tetrahydronaphthalene analogues. The analysis indicated that steric constraints at the benzylic position in the bicyclic analogues may be an important factor for their unfavorable interaction with the receptor.

Monoquaternary neuromuscular blocking agents based on 1 tetralone and 1 indanone

The preparation of three isomeric 1 tetralone hydrazones and three isomeric 1 indanone hydrazones possessing a single quaternary ammonium center is described. Several of the compounds possessed significant neuromuscular blocking activity, and two approached suxamethonium in potency. 1H NMR evidence obtained from a study of the N,N dimethylhydrazones indicated that the hydrazones adopted an E configuration in solution.